BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32667492)

  • 1. Trained innate immunity, COVID-19 therapeutic dilemma, and fake science.
    Belizário JE
    Clinics (Sao Paulo); 2020; 75():e2124. PubMed ID: 32667492
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG-induced trained immunity: can it offer protection against COVID-19?
    O'Neill LAJ; Netea MG
    Nat Rev Immunol; 2020 Jun; 20(6):335-337. PubMed ID: 32393823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
    O'Connor E; Teh J; Kamat AM; Lawrentschuk N
    Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19: the new challenge for rheumatologists. First update.
    Ferro F; Elefante E; Puxeddu I; Baldini C; Bartoloni E; Baratè C; Galimberti S; Talarico R; Mosca M; Bombardieri S
    Clin Exp Rheumatol; 2020; 38(3):373-382. PubMed ID: 32452355
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
    Gursel M; Gursel I
    Allergy; 2020 Jul; 75(7):1815-1819. PubMed ID: 32339299
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunology of COVID-19: Current State of the Science.
    Vabret N; Britton GJ; Gruber C; Hegde S; Kim J; Kuksin M; Levantovsky R; Malle L; Moreira A; Park MD; Pia L; Risson E; Saffern M; Salomé B; Esai Selvan M; Spindler MP; Tan J; van der Heide V; Gregory JK; Alexandropoulos K; Bhardwaj N; Brown BD; Greenbaum B; Gümüş ZH; Homann D; Horowitz A; Kamphorst AO; Curotto de Lafaille MA; Mehandru S; Merad M; Samstein RM;
    Immunity; 2020 Jun; 52(6):910-941. PubMed ID: 32505227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
    Ayoub BM
    Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free Therapies: Novel Approaches for COVID-19.
    Maron-Gutierrez T; Rocco PRM
    Front Immunol; 2020; 11():583017. PubMed ID: 33072130
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis.
    Meenakshisundaram R; Senthilkumaran S; Thirumalaikolundusubramanian P
    Med Hypotheses; 2020 Oct; 143():109849. PubMed ID: 32480250
    [No Abstract]   [Full Text] [Related]  

  • 12. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
    Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
    Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and management of neuroimmunological disorders.
    Hartung HP; Aktas O
    Nat Rev Neurol; 2020 Jul; 16(7):347-348. PubMed ID: 32444648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is BCG vaccination affecting the spread and severity of COVID-19?
    Ozdemir C; Kucuksezer UC; Tamay ZU
    Allergy; 2020 Jul; 75(7):1824-1827. PubMed ID: 32330314
    [No Abstract]   [Full Text] [Related]  

  • 17. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
    Dong H
    Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
    Schaaf HS; du Preez K; Kruger M; Solomons R; Taljaard JJ; Rabie H; Seddon JA; Cotton MF; Tebruegge M; Curtis N; Hesseling AC
    Int J Tuberc Lung Dis; 2020 Jul; 24(7):732-734. PubMed ID: 32718410
    [No Abstract]   [Full Text] [Related]  

  • 19. Respiratory Virus Infections: Understanding COVID-19.
    Subbarao K; Mahanty S
    Immunity; 2020 Jun; 52(6):905-909. PubMed ID: 32497522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Trained immunity" from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes.
    Singh S; Maurya RP; Singh RK
    PLoS Pathog; 2020 Oct; 16(10):e1008969. PubMed ID: 33119725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.